Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Investing Activities: 2023-2024

Historic Cash from Investing Activities for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to -$441,000.

  • Camp4 Therapeutics' Cash from Investing Activities was N/A to $36,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$669,000, marking a year-over-year change of. This contributed to the annual value of -$441,000 for FY2024, which is 34.96% up from last year.
  • According to the latest figures from FY2024, Camp4 Therapeutics' Cash from Investing Activities is -$441,000, which was up 34.96% from -$678,000 recorded in FY2023.
  • Camp4 Therapeutics' 5-year Cash from Investing Activities high stood at -$441,000 for FY2024, and its period low was -$678,000 during FY2023.
  • Its 2-year average for Cash from Investing Activities is -$559,500, with a median of -$559,500 in 2023.
  • Data for Camp4 Therapeutics' Cash from Investing Activities shows a peak YoY soared of 34.96% (in 2024) over the last 5 years.
  • Over the past 2 years, Camp4 Therapeutics' Cash from Investing Activities (Yearly) stood at -$678,000 in 2023, then skyrocketed by 34.96% to -$441,000 in 2024.